AAPG $23.00 (-0.17%) Quote details

Establish your trading edge with a set of smart tools for serious trades. Upgrade Account
stock

Ascentage Pharma Group International

NASDAQ | AAPG

23

USD

-0.04 (-0.17%)

AT CLOSE (AS OF Apr 2, 2025)

$6.4B

MARKET CAP

-

P/E Ratio

-0.17

EPS

$24

52 Week High

$17

52 Week Low

TECHNOLOGY

Sector

AAPG Chart

1D
Area

Trade Smarter

Take control of your trading journey with a set of smart tools for serious trades

Icon For Time-schedule

Backtests

Strategy Backtester designed to automate your backtesting and revolutionize the way you trade

Learn More
Icon For Search

Scanner

Leverage the power of AI to detect valuable opportunities and gain the most out of the markets.

Learn More

Signals

Automate your trading workflow with AI-powered trading signals to execute trades automatically.

Learn More
Icon For Clipboard-list

Journal

Record your trades and performance to improve your trading with AfterPullback’s Trading Journal

Learn More

AAPG Technicals

Tags:

AAPG Financials

yearly Balance Sheet (As of Dec 31, 2023)

Field Value (CNY)
Total Assets $2.5B
Total Current Assets $1.3B
Cash And Cash Equivalents At Carrying Value $1.1B
Cash And Short Term Investments $1.1B
Inventory $16M
Current Net Receivables -
Total Non Current Assets $1.2B
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $85M
Intangible Assets Excluding Goodwill $85M
Goodwill $25M
Investments -
Long Term Investments -
Short Term Investments -
Other Current Assets -
Other Non Current Assets -
Total Liabilities $2.4B
Total Current Liabilities $934M
Current Accounts Payable -
Deferred Revenue -
Current Debt -
Short Term Debt -
Total Non Current Liabilities $1.5B
Capital Lease Obligations $23M
Long Term Debt $1.2B
Current Long Term Debt $607M
Long Term Debt Noncurrent -
Short Long Term Debt Total -
Other Current Liabilities -
Other Non Current Liabilities -
Total Shareholder Equity $60M
Treasury Stock -
Retained Earnings -$5.4B
Common Stock -
Common Stock Shares Outstanding $290M

AAPG Profile

Ascentage Pharma Group International Profile

Sector: TECHNOLOGY

Industry: GENERAL

Ascentage Pharma Group International, a clinical-stage biotechnology company, develops therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in Mainland China. The company is headquartered in Suzhou, China.

Discover more tools and features to empower your trading
Explore Features

Quotes and other market data may be delayed by 15 minutes or more. Financial data is provided by financial exchanges and other content providers and may be delayed as specified by financial exchanges or other data providers. AfterPullback does not verify any data and disclaims any obligation to do so. The information contained on this website is not intended as, and shall not be understood as, financial advice. The website does not operated by attorney, accountant or financial advisor and the information contained on this website is not a substitute for financial advice from a professional who is aware of the facts and circumstances of your individual situation. Nothing available on or through this website should be understood as a recommendation that you should not consult with a financial professional to address your particular information.